SEC Form 4 · accession 0000939767-19-000010
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J. Haley
Officer — Sr. Vice President, Commercial
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 7, 2019 | M | 1,560 | $5.82 | A | 98,571 | D | |
| Common Stock | Jan 7, 2019 | S | 1,560 | $21.50 | D | 97,011 | D | |
| Common Stock | Jan 7, 2019 | M | 4,000 | $1.76 | A | 101,011 | D | |
| Common StockF3 | Jan 7, 2019 | S | 4,000 | $21.52 | D | 97,011 | D | |
| Common Stock | Jan 8, 2019 | M | 2,000 | $1.76 | A | 99,011 | D | |
| Common Stock | Jan 8, 2019 | S | 2,000 | $23.00 | D | 97,011 | D | |
| Common Stock | Jan 9, 2019 | M | 1,560 | $5.82 | A | 98,571 | D | |
| Common Stock | Jan 9, 2019 | S | 1,560 | $23.50 | D | 97,011 | D | |
| Common Stock | holding | — | — | — | 23,539 | I | By spouse | |
| Common StockF4 | holding | — | — | — | 10,283 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F5 | $5.82 | Jan 7, 2019 | M | 1,560 | D | Sep 30, 2014 | Sep 29, 2020 | Common Stock | 1,560 | 6,240 | D |
| Option (right to buy)F6 | $1.76 | Jan 7, 2019 | M | 4,000 | D | Nov 17, 2015 | Nov 16, 2021 | Common Stock | 4,000 | 27,375 | D |
| Option (right to buy)F6 | $1.76 | Jan 8, 2019 | M | 2,000 | D | Nov 17, 2015 | Nov 16, 2021 | Common Stock | 2,000 | 25,375 | D |
| Option (right to buy)F5 | $5.82 | Jan 9, 2019 | M | 1,560 | D | Sep 30, 2014 | Sep 29, 2020 | Common Stock | 1,560 | 4,680 | D |
Explanation of responses
- F1Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018.
- F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.03 to $22.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- F4Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 7, 2019.
- F5The option, representing the right to purchase a total of 7,800 shares of Exelixis, Inc. common stock, became fully exercisable on September 30, 2017.
- F6The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018.